Clinical trial
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees…
NCT00420524 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00420524 |
|---|---|
| Title | A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function |
| Official title | An Open-label, Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Malignancies, Tumors |
| Intervention type | Drug |
| Interventions | Patupilone/EPO906 |
| Enrollment | 36 |
| Start date | Jan 1, 2006 |
| Primary completion | Jul 1, 2010 |
| First posted | Jan 11, 2007 |
| Last update posted | Dec 9, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: